Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06.
about
Mechanisms of Antimicrobial Resistance in ESKAPE PathogensSurveillance of antibiotic resistanceAntibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Coagulase-negative staphylococci.Daptomycin for methicillin-resistant Staphylococcus epidermidis native-valve endocarditis: a case report.Clinical Characteristics of Methicillin-resistant Coagulase-negative Staphylococcal Bacteremia in a Tertiary Hospital.Novel antibacterial proteins from the microbial communities associated with the sponge Cymbastela concentrica and the green alga Ulva australis.Waves of resistance: Staphylococcus aureus in the antibiotic era.Whole-genome sequencing reveals clonal expansion of multiresistant Staphylococcus haemolyticus in European hospitals.An unusual class of anthracyclines potentiate Gram-positive antibiotics in intrinsically resistant Gram-negative bacteria.The longitudinal prevalence of MRSA in care home residents and the effectiveness of improving infection prevention knowledge and practice on colonisation using a stepped wedge study designEpidemiology of antimicrobial resistance in bloodstream infections.Hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) in ItalyGuidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom.Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections.Clinical relevance of the ESKAPE pathogens.Bromomethylthioindole Inspired Carbazole Hybrids as Promising Class of Anti-MRSA Agents.Isolation of a small molecule with anti-MRSA activity from a mangrove symbiont Streptomyces sp. PVRK-1 and its biomedical studies in Zebrafish embryosAntimicrobial Resistance Profile of Planktonic and Biofilm Cells of Staphylococcus aureus and Coagulase-Negative Staphylococci.Vancomycin MIC for methicillin-resistant coagulase-negative Staphylococcus isolates: evaluation of the broth microdilution and Etest methods.Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.Methicillin-resistant Staphylococcus aureus in Northeastern Scotland in 2003 to 2007: evolving strain distribution and resistance patterns.Aminoglycoside-resistant staphylococci in Greece: prevalence and resistance mechanisms.Lack of upward creep of glycopeptide MICs for methicillin-resistant Staphylococcus aureus (MRSA) isolated in the UK and Ireland 2001-07.Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).Antimicrobial Susceptibility and Enterotoxin-Encoding Genes in Staphylococcus spp. Recovered from Kitchen Equipment from a University Hospital in Rio de Janeiro, Brazil.Surveillance of infection status of drug resistant Staphylococcus aureus in an Indian teaching hospital.Comparative activity of ceftobiprole against coagulase-negative staphylococci from the BSAC Bacteraemia Surveillance Programme, 2013-2015
P2860
Q26747594-154FD565-08EC-42D8-9249-830EEE1B16A7Q28082571-2D897369-F2B0-49D9-ABF1-8C7FB339F111Q30238945-5D6224A3-3936-4226-8143-379A8CA14C34Q30401758-4ABED252-6D4F-4A4C-8929-F9A171FF7C28Q33718381-9A1F95EC-B37B-4562-B9E6-2C1F37BF97B8Q33760734-90F0F811-8AE4-49FC-9E5B-D34951909D06Q33779865-71E760BC-177C-40C0-962B-2CC9E71AFA6FQ33854398-B0B80C5D-4303-456F-BEBE-0B9A969F63BCQ34331051-646757D9-DE2C-4213-9BDF-CC1EFFF22CD5Q35120382-A21932E3-F19D-4E5C-8886-00B622D046D3Q35753902-51C0600C-F346-44CB-8397-1F1185CFC809Q36913239-79A4A118-FC24-4546-9C0A-A04D2A5997DFQ37255571-FA8F9D2B-8110-423B-92E1-684107991AC7Q37413851-0280662C-4CF6-4488-A7E3-3F53581C6AF9Q37593094-7907168B-0354-4B2D-8B5B-17F417C05A77Q38086338-B9B5F11A-18B0-493E-BEF3-BDCC77BA6807Q39085473-56BB06C9-ED12-40EE-9BA8-BC852F63A858Q39508946-AC8B251D-A5A6-4756-9A6E-85725D032CF5Q41190987-5B6C4104-69F1-4244-A4CC-EF210C7483C0Q41428954-795E00A6-C50C-4DF1-B5CE-827E3A9CA780Q41874503-AFD58A54-2814-47B6-A7F2-D631D265CB64Q42249678-B873CCB7-11E5-41A4-B171-1D3EC7106886Q42772843-A5690967-E5E8-41A1-AA79-1795AC9763E6Q44322222-A74E7B96-AA60-46EC-B520-0C7CB1A66CFDQ47253276-73A5C865-767E-4BC6-9643-B32C425FE25AQ49833719-5150BD76-1C24-4B45-AEDA-DB672F4B8E6EQ53695675-1CFF53A2-0714-4E3B-97EE-BA1A3261302BQ55608914-3CBE1B96-EB77-44A9-A8DD-DFA41A400E86Q56835135-FC201178-255C-460D-A2DB-F40C2E8E6106
P2860
Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Non-susceptibility trends amon ...... n the UK and Ireland, 2001-06.
@ast
Non-susceptibility trends amon ...... n the UK and Ireland, 2001-06.
@en
Non-susceptibility trends amon ...... n the UK and Ireland, 2001-06.
@nl
type
label
Non-susceptibility trends amon ...... n the UK and Ireland, 2001-06.
@ast
Non-susceptibility trends amon ...... n the UK and Ireland, 2001-06.
@en
Non-susceptibility trends amon ...... n the UK and Ireland, 2001-06.
@nl
prefLabel
Non-susceptibility trends amon ...... n the UK and Ireland, 2001-06.
@ast
Non-susceptibility trends amon ...... n the UK and Ireland, 2001-06.
@en
Non-susceptibility trends amon ...... n the UK and Ireland, 2001-06.
@nl
P2093
P356
P1476
Non-susceptibility trends amon ...... n the UK and Ireland, 2001-06.
@en
P2093
BSAC Working Parties on Resistance Surveillance
David M Livermore
Geraldine Brick
Mark Lillie
Rosy Reynolds
Russell Hope
P304
P356
10.1093/JAC/DKN353
P407
P478
62 Suppl 2
P577
2008-11-01T00:00:00Z